ReviewCurrent cardiology reports2025
Addressing Diastolic Dysfunction in the Congenital Heart Population.
Review in Current cardiology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThis review summarizes recent advances in the evaluation of diastolic dysfunction and management considerations in the unique congenital heart disease population. RECENT
findingsDiastolic dysfunction is prevalent in a number of congenital lesions. Non-invasive assessment methods have varying applicability depending on the specific lesion. Lesions with a systemic left ventricle can likely be accurately assessed with traditional echocardiographic techniques while higher complexity lesions may be better suited to emerging techniques including 4D-flow cardiac MRI and analysis of late gadolinium enhancement. Diagnosis and management are tailored to the individual patient and include surveillance, medication, lifestyle modification and occasionally device therapy. Diastolic dysfunction is increasingly recognized across the spectrum of the expanding, aging congenital heart population. Ongoing study of the unique mechanisms in individual lesions is needed to determine how best to assess for and intervene upon this pathology.
Indexed as
Identifiers
40938505What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.